Latest From Biotech Now

What OxyContin Tells Us About the Value of “Evergreening” and Patents

Be.Futureproof

A few weeks ago, the  FDA announced that they would not allow generic versions of older versions of OxyContin. The original formulation of OxyContin goes off patent today. The original formulation did not have “tamper-resistant qualities” that prevent people from “crushing, breaking, and dissolution using a variety of tools and solvents.”  The article reports that the decision will keep Teva Pharmaceuticals and Impax Laboratories from making the older version which the FDA has determined is too dangerous Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , ,

Biopharmaceuticals and Accountable Care Organizations: Balancing Cost and Quality

Biopharmaceuticals and Accountable Care Organizations: Balancing Cost and Quality

As biopharmaceutical manufacturers consider the new reality of accountable care organizations (ACOs) and the impact on their businesses, they must be ready to demonstrate the value of their products in ways that recognize the fine balance of cost and quality that ACO and ACO-like models seek to achieve. According to panelists speaking at the 2013 BIO International Convention session entitled, “Accountable Care Organization (ACO) Framework for Biopharmaceuticals,” there are three primary considerations when it comes Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,

BioGENEius – From Student Participant to Judge

BioGENEius – From Student Participant to Judge

It’s been two years since I participated as a student in BioGENEius. Last year I presented my work at the White House Science Fair and now I am privileged to attend BioGENEius 2013 as a judge. BioGENEius 2013 is in Chicago this year and as a student at Northwestern University in nearby Evanston, I jumped at the chance to attend again. As I joined the judges and learned about their backgrounds, I felt honored to Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

How to Drive International Innovation: Scientific American Worldview

Worldview Super Session

Which countries are winning the innovation game? Will the U.S. maintain its leadership position in the future? Have emerging markets lived up to the hype? Which new partnerships are transforming industries? For the fifth year, Scientific American (SA) released their Worldview: A Global Biotechnology Perspective report at the 2013 BIO International Convention in Chicago. Included in this year’s report is the longest list of country rankings that SA has ever compiled and the numbers reveal Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

RFS Under Fire: History, Significance and Current Issues

RFS Under Fire: History, Significance and Current Issues

Unquestionably, the federal Renewable Fuel Standard (RFS) is the most important policy affecting the U.S. biofuels industry. It supports the market for first-generation biofuels, creates the market for second-generation biofuels and it is vital to boosting the nation’s reliance on advanced biofuels from non-food-related feedstocks. This pivotal policy, however, has vocal opponents who have filed lawsuits against the Environmental Protection Agency (EPA), held Congressional hearings and formed stakeholder coalitions. On Wednesday, BIO ’ s International Convention featured Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , , ,